SEL Bioengineering

Advancing healthcare through research and engineering.

Built on 40 years of precision engineering and world-class manufacturing at Schweitzer Engineering Laboratories, Inc. (SEL), SEL Bioengineering brings together reliable technologies and evidence-based healthcare practices to improve quality of life. In 2024, Dr. Georgina Lynch joined SEL as a principal scientist to lead a team dedicated to the research and development of the investigational APS Detect Handheld Pupillometer device. SEL Bioengineering is exploring how handheld pupillometry could help expedite the diagnostic process and reduce associated stress for families, with the goal of improving outcomes for children with autism. The team is currently working through FDA regulatory and compliance requirements.

Close-up of pen indicating trends in a digital data graph.

About the Clinical Trial

SEL is sponsoring an FDA clinical trial called Effectiveness of the Autism Pupil Screen (APS) Detect Pupillometer for Identifying Autism Spectrum Disorder (ASD) in Routine Healthcare. This trial will examine the safety and effectiveness of an investigational handheld pupillometer designed to help healthcare professionals screen for ASD in children ages two to five years old in routine well-child exams. View trial details

Development Team

The development team is led by Dr. Lynch, whose research focuses on early identification of autism using pupillometry and eye tracking technology to improve screening practices by healthcare providers. With a background in neuroscience and speech-language pathology and a 20-year history working with the autism community, she brings the technical expertise and clinical understanding required to lead the innovation of SEL Bioengineering. The team consists of engineers with expertise in research and development, image processing, optics, precision signal detection, bioengineering, software development, UI/UX design, and quality assurance.